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Acute Myelomonocytic Leukemia Presenting
as a Benign-Appearing Cutaneous Eruption
Howard P. Horlick, MD; David N. Silvers, MD; Elizabeth H. Knobler, MD; John T. Cole, MD
\s=b\Aleukemic leukemia cutis is a rare condition in which
patients have skin lesions containing leukemic cells be-
fore evidence of leukemia can be detected in the periph-
eral blood. There are only 23 cases of this phenomenon
documented in the English literature. We describe a
62-year-old woman who developed a diffuse, clinically
benign-appearing cutaneous eruption, which histologi-
cally showed an atypical infiltrate of cells, 4 months
before leukemic cells were found in her peripheral blood
and the diagnosis of acute myelomonocytic leukemia was
made by bone marrow aspiration. This case illustrates the
difficulty in diagnosing leukemia cutis from examination of
routine histologic sections and the importance of special-
ized marker studies in determining the cause of an atyp-
ical cellular infiltrate of the skin. It also illustrates how
leukemia cutis can masquerade as a clinically benign-ap-
pearing cutaneous eruption in a seemingly healthy patient
with normal blood parameters.
(Arch Dermatol. 1990;126:653-656)
The cutaneous manifestations of leukemias can bedivided into nonspecific lesions (leukemids) con¬
taining no leukemic cells, and specific lesions (leuke¬
mia cutis). Leukemids (the term was coined by
Audry1) may result from immunologie responses to
tumor antigens and include hemorrhagic lesions,
generalized pruritus, exfoliative erythroderma, pyo-
derma gangrenosum, urticaria, erythema multi-
forme, erythema nodosum, panniculitis, hyperpig-
mentation, and morbilliform eruptions. Nonspecific
cutaneous lesions are found in approximately 30% of
patients suffering from leukemia.2 Leukemia cutis, in
which leukemic cells are found in skin lesions, is much
less common. The incidence varies with the type of
leukemia; the myeloid leukemias are marked by cuta¬
neous involvement more frequently than other types
of leukemia. Skin involvement typically occurs late in
the course of leukemia cutis. However, occasional
cases of leukemic infiltrates appearing in the skin
prior to peripheral blood involvement (aleukemic
leukemia cutis) can be found in the literature.
We report a case of acute myelomonocytic leukemia
that presented as a clinically benign-appearing cuta¬
neous eruption 4 months before evidence of leukemia
could be detected in the peripheral blood.
REPORT OF A CASE
A 62-year-old woman, originally from Ecuador, pre¬
sented to the Dermatology Clinic of the Columbia-Presby¬
terian Medical Center, New York, NY, with a 2-month his¬
tory of a nonpruritic eruption on her chest, abdomen, back,
buttocks, arms, and thighs, with occasional mild involve¬
ment of the lateral aspects of her face. She reported that the
eruption began on her upper torso and spread to the other
areas over approximately 2 weeks, and that individual
lesions waxed and waned over several days and were
stress-related. Her medical history was noncontributory,
and her review of systems was negative. She was receiving
no medications.
Physical examination revealed hundreds of erythema¬
tous to violaceous 2- to 4-mm dome-shaped papules ran¬
domly distributed over the above-mentioned areas (Figs 1
and 2). Initially, her face was free of lesions. On subsequent
clinic visits, 20 to 50 similar lesions were occasionally noted
on the lateral aspects of her face. The lesions were, in fact,
transient, but the patient suffered from successive crops of
lesions. The results of her physical examination were oth¬
erwise unremarkable. She had no palpable lymphadenopa-
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Fig 1.—The patient's upper back shows numerous papules ar¬
ranged in a diffuse fashion.
Fig 2.—The lesions measure 2 to 4 mm in diameter and are pink
to violaceous.
Fig 3.—There is a thin zone of con¬
nective tissue separating the normal-
appearing epidermis from a dermal in¬
filtrate composed of atypical mononu¬
clear cells (hematoxylin-eosin, X100).
Fig 4.—The atypical cells are hyper-
chromatic with large nuclei. They infil¬
trate between collagen bundles in
"single file" fashion (hematoxylin-
eosin, X400).
thy, hepatosplenomegaly, or gingival hypertrophy.
Biopsy specimens showed a grenz zone of normal connec¬
tive tissue separating normal epidermis from a diffuse in¬
filtrate of atypical mononuclear cells in the upper half of the
dermis. The cells were arranged in strands and cords. Some
cells had kidney bean-shaped nuclei, and there were scat¬
tered mitotic figures (Figs 3 and 4). Results of immunoper¬
oxidase studies were positive for the common leukocyte an¬
tigen, indicating that the atypical cells were of
hematopoietic origin.
The patient's hemoglobin was 141 g/L; platelet count,
357 X 109/L; and white blood cell count, 5.5 X 10VL, with
0.35 polycytes, 0.01 band cells, 0.49 lymphocytes, 0.11 mono-
cytes, and 0.04 eosinophils. Her chemistry profile was nor¬
mal, and her erythrocyte sedimentation rate was 16 mm/h.
Skin biopsies for monoclonal antibody studies were per¬
formed; the cells in the infiltrate were positive for Leu-1 and
Leu-9 but negative for CD3, CD4, and CD8, suggesting an
atypical T-cell lymphoma. Her complete blood cell count at
this time (3 months after developing the eruption and 1
month after presentation to our clinic) was essentially un¬
changed: hemoglobin, 140 g/L; platelets, 274 X lO'/L; and
leukocytes, 5.2 X 109/L, with 0.25 polycytes, 0.02 band cells,
0.62 lymphocytes, 0.06 monocytes, and 0.05 eosinophils. The
patient was asymptomatic except for the rash.
Bone marrow aspiration was performed, and the major-
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ity of the cells in her marrow expressed myeloid antigens
MY4, Mol, and LEUM-1, consistent with a diagnosis of
acute myelomonocytic leukemia (French-American-British
M4).3 A repeated skin biopsy specimen was studied for
AML1-99, AML2-23, PM81, and HL60-251. The cellular in¬
filtrate showed surface immunoreactivity with PM81 and
some weak immunoreactivity with AML1-99, consistent
with a myeloid infiltrate.4 On the day of the bone marrow
aspiration (2 months after presenting to our clinic), her
peripheral blood was unequivocally abnormal for the first
time, with the following values: hemoglobin, 100 g/L; plate¬
lets, 212 X lO'/L; and leukocytes, 2.9 X 107L, with 0.12
polycytes, 0.38 lymphocytes, 0.10 atypical lymphocytes, and
0.40 monocytes. Her chemistry profile remained normal, but
her erythrocyte sedimentation rate rose to 83 mm/h. One
week later, her white blood cell count was 3.6 X 10VL, with
0.07 polycytes, 0.02 band cells, 20.0 metamyelocytes, 0.10
blast cells, 0.30 lymphocytes, 0.48 monocytes, and 0.01
eosinophils. She still reported feeling fine.
Treatment with cytarabine and daunorubicin was begun.
Her skin lesions regressed completely within 2 days. Undi-
agnosed fevers were treated with antibiotics, and anemia
and thrombocytopenia were treated with packed red blood
cell and platelet transfusions. One week after completion of
the first course of chemotherapy, bone marrow aspiration
revealed no evidence of leukemia. Two weeks later, she was
noted to have 100 to 200 erythematous papules on the lat¬
eral aspects of her face, neck, shoulders, upper torso, and
upper arms. Skin biopsy again revealed an infiltrate of
atypical cells. Bone marrow aspiration showed no atypical
cells. She was treated with high-dose cytarabine and
asparaginase, with rapid resolution of all cutaneous lesions.
She subsequently developed nadir sepsis with Escherichia
coli and Serratia marcescens and a lesion of ecthyma gan-
grenosum of her left axilla, the culture of which yielded S
marcescens. Her infection gradually resolved with antibi¬
otic therapy.
On a subsequent outpatient follow-up visit, she was again
noted to have recurrence of the erythematous papular
eruption, primarily on her arms. Chemotherapy with oral
6-thioguanine was instituted and resulted in resolution of
the skin lesions. Subsequently, she was maintained on
intermittent maintenance therapy with oral 6-thioguanine.
Follow-up bone marrow aspiration showed mild myeloid
immaturity without evidence of overt leukemia. She is cur¬
rently receiving no therapy, her blood counts are normal,
and her skin remains clear.
COMMENT
Leukemia cutis is a cutaneous eruption in which
leukemic cells are present in the skin lesions. The in¬
cidence of leukemia cutis varies with the type of leu¬
kemia; it has been reported in 10% to 50% of patients
with monocytic leukemia, and in 6% to 20% of those
with granulocytic and lymphocytic leukemias.5 The
clinical picture of leukemia cutis is highly variable
and includes macules, papules, nodules, plaques, ec¬
chymoses, palpable purpura, ulcers, erythroderma,
bullae, and gingival hypertrophy." Leukemia cutis is
not a clinical diagnosis; biopsy is required. Routine
hematoxylin-eosin staining of biopsy specimens re¬
veals an atypical cellular infiltrate, but frequently
additional studies, such as with monoclonal anti¬
bodies, are required to characterize the cells.
Aleukemic leukemia cutis is a form of leukemia cu¬
tis in which, initially, no leukemic cells are found in
the blood and in which the total white blood cell count
is normal or reduced.7 A retrospective study revealed
that 55% of patients with leukemia cutis developed
skin lesions 1 month to several years after the diag¬
nosis was made, 38% had concomitant involvement,
and 7% had specific skin lesions preceding involve¬
ment of peripheral blood.6 A review of the English
literature reveals only 23 verified cases of leukemia
cutis developing before involvement of the peripheral
blood. These included 5 cases of acute myelomonocytic
leukemia,812 2 of acute monocytic leukemia,1314 9 of
acute granulocytic leukemia,615 " 4 of chronic lympho¬
cytic leukemia,6 and 3 of acute lymphocytic leu¬
kemia.1820
Our case is an example of the rare occurrence of
leukemia presenting as a benign-appearing cutaneous
eruption in a patient with no systemic manifestations
or complaints and with normal blood parameters.
When we first saw the patient, the clinical differen¬
tial diagnosis included viral exanthem, drug eruption,
secondary syphilis, urticaria, sarcoidosis, atypical
pityriasis rosea, and atypical lymphomatoid papulo¬
sis. Routine histologie sections of biopsy specimens
showed an atypical cellular infiltrate. The arrange¬
ment and cytology of the cells suggested metastatic
carcinoma, leukemia, or lymphoma. Immunoperoxi¬
dase studies confirmed the hematopoietic origin of the
cells but gave confusing results, suggestive of an
atypical T-cell lymphoma.
The diagnosis of acute myelomonocytic leukemia in
our patient was made by bone marrow aspiration. We
have no way of knowing if the diagnosis could have
been made earlier if the marrow aspiration had been
performed sooner. Initially, the panel of monoclonal
antibodies used to study the atypical cutaneous infil¬
trate did not include myeloid markers. Subsequent
skin biopsy samples were studied with an expanded
panel of monoclonal antibodies, and the myeloid
origin of the infiltrate was confirmed. This illustrates
the importance of using a panel of monoclonal anti¬
bodies, including myeloid markers, in ascertaining
the nature of a cutaneous lesion of hematopoietic or¬
igin. Although cells of lymphocytic origin are found in
the vast majority of lymphoreticular malignancies
involving the skin (ie, cutaneous T-cell lymphoma),
the use of markers that primarily stain cells of lym¬
phocytic origin can result in a misdiagnosis. Cross-
reactivity between lymphoid and myeloid cells may
occur with Leu-1 and the other antibodies initially
used to evaluate the skin biopsy specimen.2122
It is puzzling that leukemic cells can be found in the
skin when they cannot be detected in the peripheral
blood. Even after the diagnosis of acute myelomono¬
cytic leukemia was made, no suspicious-looking cells
could be found on review of the early peripheral
smears. The frequency with which acute myelomono¬
cytic leukemia localizes in the skin does not correlate
with the peripheral white blood cell count,23 suggest¬
ing that cutaneous factors or specific characteristics
of the leukemic cells are important determinants of
cutaneous localization.24
In summary, our case demonstrates several impor-
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tant points: (1) leukemia can present as a cutaneous
eruption; (2) the eruption may be nonspecific and be¬
nign-appearing; (3) the eruption may precede periph¬
eral blood involvement and other evidence of systemicillness by months; (4) routine histologie sections are
insufficient for classification of an atypical cellular
infiltrate; and (5) although most cutaneous eruptions
of lymphoreticular origin are lymphocytic, mono¬
clonal antibodies specific for myeloid cells must be
included in the panel to prevent a delay in diagnosis
and specific therapy.
The authors gratefully acknowledge Vincent A Memoli, MD, of
Dartmouth Medical School, Hanover, NH, for performing the PM
81, AML 2-23, and AML 1-99 marker studies.
References
1. Audry C. Sur les leucemides. Bull Soc Fr Dermatol Syphiligr.
1902;13:118-121.
2. Stawiski MA. Skin manifestations of leukemias and lympho-
mas. Cutis. 1978;21:814-818.
3. Griffin J, Nelson D, Davis R, et al. Clinical correlations of sur-
face antigen phenotypes in acute non-lymphocytic leukemia(ANLL): a prospective multi-institutional study. Proc Am Soc ClinOncol. 1984;3:195. Abstract.
4. Ball ED, Graziano RF, Fanger MW. A unique antigen ex-pressed on myeloid cells and acute leukemia blast cells defined by
a monoclonal antibody. J Immunol. 1983;130:2937-2941.
5. Braverman IM. Skin Signs ofSystemic Disease. 2nd ed. Phil-
adelphia, Pa: WB Saunders Co; 1981:179.
6. Su WPD, Buechner SA, Li CY. Clinicopathologic correlations
in leukemia cutis. J Am Acad Dermatol. 1984;11:121-128.
7. Friedman IA, Leithold SL. The diagnosis of leukemia. In:Curtis AC, ed. Leukemia Cutis. Springfield, Ill: Charles C Thomas
Publisher; 1960:408.
8. Haubenstock A, Zalusky R, Ghali VS, Mernick MH, MalamudSC, Stein JJ. Isolated leukemia cutis: a case report. Am J Hematol.
1987;24:437-439.
9. DeConinck A, DeHou MF, Peters 0, Van Camp B, Roseeuw DI.
Aleukemic leukemia cutis: an unusual presentation of acute my-
elomonocytic leukemia. Dermatologica. 1986;172:272-275.
10. Statham BN, Fairris GM, Cotterill JA. Atypical eruptivehistiocytosis: a marker of underlying malignancy? Br JDermatol.
1984;110:103-105.
11. Strayer DS, Phillips GB, Herzig G, Bari W, Santa Cruz DJ.
Acute myelomonocytic leukemia presenting as a primary cutane-
ous lymphoma of true histiocytes. JAm Acad Dermatol. 1982;7:229\x=req-\
235.
12. Berger BJ, Gross PR, Daniels RB, Lankton BB. Leukemia
cutis masquerading as guttate psoriasis. Arch Dermatol. 1973;
108:416-418.
13. Blaustein JC, Narang S, Palutke M, Karanes C. Extramedul-
lary (skin) presentation of acute monocytic leukemia resembling
cutaneous lymphoma: morphological and immunological features.
J Cutan Pathol. 1987;14:232-237.
14. Burg G, Schmoeckel C, Braun-Falco 0, Wolff HH. Monocytic
leukemia. Arch Dermatol. 1978;114:418-420.
15. Long JC, Mihm MC. Multiple granulocytic tumors of the skin:
report of six cases of myelogenous leukemia with initial manifes-
tations in the skin. Cancer. 1977;39:2004-2016.
16. Sun NCJ, Ellis R. Granulocytic sarcoma of the skin. ArchDermatol. 1980;116:800-802.
17. Wiernik PH, Serpick AA. Granulocytic sarcoma (chloroma).Blood. 1970;35:361-369.
18. Yoder FW, Schuen RL. Aleukemic leukemia cutis. Arch Der-
matol. 1976;112:367-369.
19. Scott O. A case of primary lymphatic leukaemia of skin. Br
JDermatol Syphilol. 1951;63:371-372.
20. Cochrane T, Milne JA. Aleukaemic acute lymphoblastic leu-
kaemia presenting with cutaneous lesions. Br J Dermatol. 1974;
91:587-589.
21. Vodinelich L, Tax W, Bai Y, Pegram S, Capel P, Greaves MF.
A monoclonal antibody (WT1) for detecting leukemias of T-cell
precursors (T-ALL). Blood. 1983;62:1108-1113.
22. Greaves MF, Chan LC, Furley AJW, Watt SM, Molgaard HV.Lineage promiscuity in hematopoietic differentiation and leuke-
mia. Blood. 1986;67:1-11.
23. Bluefarb S. Leukemia Cutis. Springfield, Ill: Charles C Tho-
mas Publisher; 1966:107-141.
24. Baden TJ, Gammon WR. Leukemia cutis in acute my-
elomonocytic leukemia: preferential localization in a recent Hick-
man catheter scar. Arch Dermatol. 1987;123:88-90.
In Other AMA Journals
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
Malignant Fibrous Histiocytoma: Heterogeneous Patterns of Intermediate Filament
Proteins by Immunohistochemistry
Markku Miettinen, MD, Yiermi Soini, MD (Arch Pathol Lab Med. 1989;113:1363-1364)
Necrobiotic Xanthogranuloma With Paraproteinemia
Richard K. Scupham, MD, PhD, David F. Fretzin, MD (Arch Pathol Lab Med.
1989;113:1389-1391)
ARCHIVES OF INTERNAL MEDICINE
Latex andVinyl Examination Gloves
Helen Rosen Kotilainen, MD, MT(ASCP), CIC; James P. Brinker, SM(AAM); Joan
Lomolino Avato, MLT(ASCP); Nelson M. Gantz, MD (Arch Intern Med. 1989;
149:2749-2753)
Downloaded From: http://archderm.jamanetwork.com/ by a UQ Library User  on 11/26/2015
